Dr. Dana Tsing-Yip Lin, MD

Dr. Lin practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Lin's NPI, 1538301171, was assigned on March 27, 2009. Dr. Lin graduated from Jacobs School of Medicine and Biomedical Sciences in 2004. Dr. Lin holds California license A118251.

Dr. Lin's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Lin's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Lin is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Lin to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Lin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 5 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Lin is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Lin's licenses on file in 3 states: California, Massachusetts and New Jersey.

Dmand AI lists cancerous skin growth removal and thyroid surgery among the conditions Dr. Lin treats.

CMS data shows 122 Medicare services from Dr. Lin across 3 procedure codes in 2024, for 100 Medicare patients. Medicare paid $40,317 for them.

CMS counts 100 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 60, with 75% women.

In 2024, Dr. Lin wrote 21 Medicare Part D claims for 13 patients. 67% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $76 in total drug cost. In 2020, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Lin for performance year 2024, reported as part of a group. Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 36 papers to Dr. Lin, published from 2013 to 2024. 2018 was the busiest year, with 5. The most frequent topics are General Surgery, Internship and Residency and Clinical Competence. Dr. Lin has published most often in J Surg Educ. Dr. Lin's most frequent co-authors are Cara Ann Liebert, MD, Robin Malone Cisco, MD and Electron Kebebew, MD.

CMS Open Payments shows 4 general payments to Dr. Lin from 3 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 52% of the total. Novadaq Technologies Inc. paid the most, $2,145.

Dr. Lin graduated from Jacobs School of Medicine and Biomedical Sciences in 2004. Dr. Lin is a member of ACS.

Dr. Lin is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.